三達膜(688101.SH):擬將募投項目的部分實施內容進行調整
格隆匯8月1日丨三達膜(688101.SH)公佈,公司為了便於募投項目的集中管理及資源整合,擬將募集資金投資項目的部分實施內容進行調整,具體情況如下:
“原項目”名稱:特種分離膜及其成套設備的製備與生產項目。
“新項目1”名稱:基於高性能膜應用的孝感市孝南區碧泉污水處理廠提標改造及擴建項目。
“新項目2”名稱:基於高性能膜應用的許昌市建安區污水處理廠提標改造及擴建項目。
“原項目”變更後項目募集資金總金額:3億元;已投入使用募集資金0萬元,現募集資金餘額3億元。與原項目募集資金保持一致。
“新項目1”預計正常投產併產生收益的時間:預計2022年6月達到預定可使用狀態
“新項目2”預計正常投產併產生收益的時間:預計2021年12月達到預定可使用狀態。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.